𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer

✍ Scribed by Wallin, U; Glimelius, B; Jirström, K; Darmanis, S; Nong, R Y; Pontén, F; Johansson, C; Påhlman, L; Birgisson, H


Book ID
109838737
Publisher
Nature Publishing Group
Year
2011
Tongue
English
Weight
677 KB
Volume
104
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Serum hepatocyte growth factor as a prog
✍ Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Yoshinaga Okugawa; Kouji Tanaka; Masa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 205 KB

## Abstract We previously reported that a combination of serum hepatocyte growth factor (HGF) and carcinoembryonic antigen (CEA) was useful for selecting early‐stage colorectal cancer patients with aggressive disease. The aim of the present study was to determine whether serum HGF could provide CEA

Anastomotic leaks in colorectal cancer s
✍ A. M. Akyol; J. R. McGregor; D. J. Galloway; G. D. Murray; W. D. George 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 463 KB

This study examines anastomotic leaks as a potential influence on the long term outcome of patients with colorectal cancer. 167 patients were studied who had clinical and radiological assessment of anastomotic integrity in the post-operative period, following potentially curative resections for left

Significance of transforming growth fact
✍ Shin Narai; Masahiko Watanabe; Hirotoshi Hasegawa; Hideki Nishibori; Takashi End 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB

## Abstract Transforming growth factor β1 (TGF‐β1) is thought to be involved in cancer growth and progression. TGF‐β1 changes to its active form after being secreted in its latent form. Our aim was to clarify the significance of plasma concentrations of active and total TGF‐β1 of patients with colo